Back to search

Iceland· IS-IS/1/20/097/02

Risperidone Teva GmbH

A risperidone product containing risperidonum inn, registered in Iceland by TEVA GmbH. The same ATC class is registered in 19 of our 19 countries.

ATC N05AX08

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedRisperidone Teva GmbHATCN05AX08REGISTER NO.IS-IS/1/20/097/02PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Risperidone is registered in 19 of 19 countries.

Countries holding a registration under ATC N05AX08 (risperidone), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 11 of them publish a price we can compare per daily dose

Risperidone · ATC N05AX08

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of risperidone costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.52 in Czechia to $3.93 in Switzerland — a ×7.5 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Risperidone · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.93
  • IT Italy$1.34
  • FR France$0.77
  • CZ Czechia$0.52
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Risperidonum INN
Manufacturer
TEVA GmbH
Country
Iceland (IS)
ATC code
N05AX08
ATC class
Risperidone
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

542 interactions on record for risperidone.

Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Risperidone · interactions on record

542 records

  • 45 severe
  • 286 moderate
  • 4 minor
  • 136 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • PasireotideH01CB05severe

71 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Risperidone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All risperidone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Risperdal, Risperdal Consta
  • Belgium · Risperdal, Risperdal Consta
  • Bulgaria · Медориспер, Рисар
  • Cyprus · Eperon, Risperdal
  • Czechia · Medorisper, Rileptid
  • Germany · Risperdal, Risperdal Consta
  • Denmark · Rispemyl, Risperanne
  • Estonia · Medorisper, Risperidon Actavis
  • Spain · Arketin, Risperdal
  • Finland · Rismyl, Risperdal
  • France · Risperdal, Risperdalconsta L.P.
  • United Kingdom (Northern Ireland) · Risperdal Consta, Risperidione Wockhardt Uk Ltd
  • Greece · Adovia, Axelabron
  • Croatia · Prospera, Risdonal
  • Hungary · Perdox, Rileptid
  • Ireland · Perdamel, Risperdal
  • Italy · Risperdal, Risperidone Aurobindo
  • Liechtenstein · Okedi, Risperdal Consta
  • Lithuania · Medorisper, Risperidon Actavis
  • Luxembourg · Risperdal, Risperdal Consta
  • Latvia · Medorisper, Rispaxol
  • Malta · Eperon, Evitrat
  • Netherlands · Risperdal, Risperdal Consta
  • Norway · Okedi, Risperdal
  • Poland · Orizon, Risperidon Vipharm
  • Portugal · Risperdal, Risperdal Consta
  • Romania · Rispen, Risperidonă Arena
  • Sweden · Medorisper, Rispemyl
  • Slovenia · Risperdal, Risperdal Consta
  • Slovakia · Medorisper, Rispen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c1ea60df-ff3b-43a4-8466-9053a3a359df
GET /v1/drugs/c1ea60df-ff3b-43a4-8466-9053a3a359df?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Stungulyfsstofn og leysir, forðadreifa",
  "source": "lyfjastofnun",
  "atc_raw": "N05AX08",
  "marketed": true,
  "strength": "37,5 mg",
  "ma_number": "IS/1/20/097/02",
  "substance": "Risperidonum INN",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "44147"
}

See everything about risperidone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.